SafeStart survey data: Q2
The follow-up questionnaire, Q2, was distributed 13 weeks after enrollment and aimed to identify medication use in the second trimester, defined as gestational weeks 14–26. Q2 included the repeated list of medical conditions and related medication use from Q1. The English versions of Q1 and Q2 are provided in Supplementary file 1.